Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa

Tuberculosis (TB) and viral hepatitis B and C represent significant public health concerns. Co-infection with TB and hepatitis B and/or C results in significant complications, including suboptimal treatment outcomes in TB and the development of hepatitis induced by anti-TB drugs. At present, no data...

Full description

Saved in:
Bibliographic Details
Main Authors: Armel Moumouni Sanou, Abdoulaye Dera, Jeoffray Diendere, Nina Mathuola Geneviève Ouattara, Eric Kyelem, Arhouna Siguina Traore, Arouna Dao, Arielle Sandra Bettina Badiel, Ina Marie Angèle Traore, Michel Kiréopori.B Gomgnimbou, Isidore Bonkoungou, Gautier Henri Ouedraogo
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Journal of Clinical Virology Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038025000109
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128669876420608
author Armel Moumouni Sanou
Abdoulaye Dera
Jeoffray Diendere
Nina Mathuola Geneviève Ouattara
Eric Kyelem
Arhouna Siguina Traore
Arouna Dao
Arielle Sandra Bettina Badiel
Ina Marie Angèle Traore
Michel Kiréopori.B Gomgnimbou
Isidore Bonkoungou
Gautier Henri Ouedraogo
author_facet Armel Moumouni Sanou
Abdoulaye Dera
Jeoffray Diendere
Nina Mathuola Geneviève Ouattara
Eric Kyelem
Arhouna Siguina Traore
Arouna Dao
Arielle Sandra Bettina Badiel
Ina Marie Angèle Traore
Michel Kiréopori.B Gomgnimbou
Isidore Bonkoungou
Gautier Henri Ouedraogo
author_sort Armel Moumouni Sanou
collection DOAJ
description Tuberculosis (TB) and viral hepatitis B and C represent significant public health concerns. Co-infection with TB and hepatitis B and/or C results in significant complications, including suboptimal treatment outcomes in TB and the development of hepatitis induced by anti-TB drugs. At present, no data on these co-infections are available for Burkina Faso. This study investigates the epidemiology of these co-infections in TB patients in the Hauts-Bassins region of Burkina Faso. A cross-sectional analytical study was conducted in health facilities involved in the management of TB in the Hauts-Bassins region of Burkina Faso from October 2023 to June 2024. For each consenting TB patient, data were collected. A blood sample was obtained and analyzed for a range of infection markers (HBsAg, HBV DNA, anti-HCV antibodies, and HCV RNA) and liver enzymes (ALT and γ-GT). A total of 259 TB patients were included in the study. The mean age of the participants was 39.7 ± 15.9 years. The overall prevalence of HBsAg was 10.03 % and 3.8 % for anti-HCV. Among the HBsAg-positive samples, HBV DNA was detected in all cases, with 68.2 % exhibiting a viral load exceeding 20,000 IU/mL. Elevated ALT was observed in 19.2 % of TB/HBsAg patients and in 30.0 % of TB/anti-HCV. About γ-GT, an elavated result was observed in 46.1 % of TB/HBsAg patients and 40.0 % of TB/anti-HCV patients. The results demonstrated a high prevalence of hepatitis B and intermediate exposure to HCV in TB patients. It is thus recommended that routine screening for these diseases be considered in TB patients.
format Article
id doaj-art-9ab0d3bc3c4e4d0d93b7455a0a322293
institution OA Journals
issn 2667-0380
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Journal of Clinical Virology Plus
spelling doaj-art-9ab0d3bc3c4e4d0d93b7455a0a3222932025-08-20T02:33:12ZengElsevierJournal of Clinical Virology Plus2667-03802025-06-015210021110.1016/j.jcvp.2025.100211Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West AfricaArmel Moumouni Sanou0Abdoulaye Dera1Jeoffray Diendere2Nina Mathuola Geneviève Ouattara3Eric Kyelem4Arhouna Siguina Traore5Arouna Dao6Arielle Sandra Bettina Badiel7Ina Marie Angèle Traore8Michel Kiréopori.B Gomgnimbou9Isidore Bonkoungou10Gautier Henri Ouedraogo11Laboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina Faso; Corresponding author.Laboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLa Laboratoire de Recherche en Santé Publique et Nutrition (LR-SPN), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 01 BP 545 Bobo-Dioulasso, Burkina FasoInstitut Supérieur des Sciences de la Santé (INSSA), Université́ Nazi Boni, Bobo-Dioulasso 1091, Burkina Faso; Équipe Biologie Moléculaire et Biotechnologies, Laboratoire de Recherche, Centre MURAZ, Bobo-Dioulasso, Burkina FasoLaboratory of Molecular Biology, Epidemiology and Monitoring of Bacteria and Viruses Transmitted by Food (LaBESTA), University Joseph KI-ZERBO, 03 BP 7021, Ouagadougou 03, Burkina FasoLaboratoire de Recherche sur les Maladies Infectieuses et Parasitaires (LR-MIP), Institut de Recherche en Sciences de la Santé (IRSS), 03 BP 7192 Ouagadougou, Burkina FasoTuberculosis (TB) and viral hepatitis B and C represent significant public health concerns. Co-infection with TB and hepatitis B and/or C results in significant complications, including suboptimal treatment outcomes in TB and the development of hepatitis induced by anti-TB drugs. At present, no data on these co-infections are available for Burkina Faso. This study investigates the epidemiology of these co-infections in TB patients in the Hauts-Bassins region of Burkina Faso. A cross-sectional analytical study was conducted in health facilities involved in the management of TB in the Hauts-Bassins region of Burkina Faso from October 2023 to June 2024. For each consenting TB patient, data were collected. A blood sample was obtained and analyzed for a range of infection markers (HBsAg, HBV DNA, anti-HCV antibodies, and HCV RNA) and liver enzymes (ALT and γ-GT). A total of 259 TB patients were included in the study. The mean age of the participants was 39.7 ± 15.9 years. The overall prevalence of HBsAg was 10.03 % and 3.8 % for anti-HCV. Among the HBsAg-positive samples, HBV DNA was detected in all cases, with 68.2 % exhibiting a viral load exceeding 20,000 IU/mL. Elevated ALT was observed in 19.2 % of TB/HBsAg patients and in 30.0 % of TB/anti-HCV. About γ-GT, an elavated result was observed in 46.1 % of TB/HBsAg patients and 40.0 % of TB/anti-HCV patients. The results demonstrated a high prevalence of hepatitis B and intermediate exposure to HCV in TB patients. It is thus recommended that routine screening for these diseases be considered in TB patients.http://www.sciencedirect.com/science/article/pii/S2667038025000109TuberculosisHepatitis BHepatitis CCoinfectionBurkina Faso
spellingShingle Armel Moumouni Sanou
Abdoulaye Dera
Jeoffray Diendere
Nina Mathuola Geneviève Ouattara
Eric Kyelem
Arhouna Siguina Traore
Arouna Dao
Arielle Sandra Bettina Badiel
Ina Marie Angèle Traore
Michel Kiréopori.B Gomgnimbou
Isidore Bonkoungou
Gautier Henri Ouedraogo
Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
Journal of Clinical Virology Plus
Tuberculosis
Hepatitis B
Hepatitis C
Coinfection
Burkina Faso
title Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
title_full Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
title_fullStr Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
title_full_unstemmed Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
title_short Hepatitis B and C infection in tuberculosis patients in the Hauts Bassins region of Burkina Faso, West Africa
title_sort hepatitis b and c infection in tuberculosis patients in the hauts bassins region of burkina faso west africa
topic Tuberculosis
Hepatitis B
Hepatitis C
Coinfection
Burkina Faso
url http://www.sciencedirect.com/science/article/pii/S2667038025000109
work_keys_str_mv AT armelmoumounisanou hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT abdoulayedera hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT jeoffraydiendere hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT ninamathuolagenevieveouattara hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT erickyelem hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT arhounasiguinatraore hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT arounadao hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT ariellesandrabettinabadiel hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT inamarieangeletraore hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT michelkireoporibgomgnimbou hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT isidorebonkoungou hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica
AT gautierhenriouedraogo hepatitisbandcinfectionintuberculosispatientsinthehautsbassinsregionofburkinafasowestafrica